ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 1086 • ACR Convergence 2020

    The Diagnostic Value and Clinical Significance of Myositis-Specific Antibodies in Patients Suspected to Have Autoimmune Myopathies and/or Autoimmune Rheumatic Diseases

    Sarah El Chami1, Christopher Williams1, Ghaith Noaiseh1, Amrita Bath1 and Duaa Jabari1, 1The University of Kansas Health System, Kansas city, KS

    Background/Purpose: Myositis-specific antibodies (MSA) are thought to be highly specific in patients with idiopathic inflammatory myopathies.[1] However, in clinical practice these antibodies are frequently found…
  • Abstract Number: 1092 • ACR Convergence 2020

    NMR-Based Serum Metabolomics, Is It Different in Clinico-Serological Clusters of Idiopathic Inflammatory Myositis?

    Naveen R1, Anupam Guleria2, Dinesh Kumar2, Umesh Kumar2, Anamika Anuja1, Vikas Agarwal3 and Latika Gupta4, 1Sanjay Gandhi Post graduate institute of medical sciences, Lucknow, Uttar Pradesh, India, 2Centre of Biomedical Research, Sanjay Gandhi post graduate institute of medical sciences, Lucknow, Uttar Pradesh, India, 3Sanjay Gandhi Post Graduate Institute of Medical Sciences, LUCKNOW, India, 4Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India

    Background/Purpose: Idiopathic inflammatory myositis (IIM) are rare and heterogenous. Myositis specific antibodies (MSA) show mutual exclusivity and identify specific clinical phenotypes1. Most biomarker studies are…
  • Abstract Number: 1091 • ACR Convergence 2020

    A Computer-Aided Diagnostic System for Quantitative Scoring of Extent of Interstitial Lung Disease (ILD) in Dermatomyositis/Polymyositis Associated ILD

    Sangmee Bae1, Andrea Oh2, Grace Kim3, Jonathan Goldin3 and Christina Charles-Schoeman4, 1University of California Los Angeles, Los Angeles, CA, 2National Jewish Health, Denver, CO, 3University of California, Los Angeles, Los Angeles, 4University of California, Los Angeles, Los Angeles, CA

    Background/Purpose: Interstitial lung disease (ILD) occurs in up to 80% of patients with dermatomyositis (DM) and polymyositis (PM), and is a leading cause of morbidity…
  • Abstract Number: 1097 • ACR Convergence 2020

    Immunophenotypic Characterization of Myeloid Derived Supressor Cells (MDSCs) and Their Relationship to the Clinical Characteristics of Patients with Inflammatory Myopathies

    Hector Culebro1, Jose Torres-Ruiz2, Fabiola Cassiano Quezada1 and Alfredo Perez Fragoso1, 1INCMNSZ, MEXICO, Mexico, 2NIAMS, National Institute of Health, Bethesda

    Background/Purpose: Myeloid derived suppressor cells (MDSCs) including their granulocyte (Gr-MDSCs) and monocyte (Mo-MDSCs) subtypes constitute a cellular subset with potent immune regulatory capacity. An augmented…
  • Abstract Number: 1099 • ACR Convergence 2020

    High Burden of Infections in Indian Patients with Idiopathic Inflammatory Myopathy: Validation of Observations from the MyoCite Dataset

    Rudrarpan Chatterjee1, Pankti Mehta2, Vikas Agarwal1 and Latika Gupta2, 1Sanjay Gandhi Post Graduate Institute of Medical Sciences, lucknow, Lucknow, Uttar Pradesh, India, 2Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India

    Background/Purpose: Infections are a major cause of morbidity and mortality in idiopathic inflammatory myopathy (IIM), more so in India.[1-3] The objective of this study was…
  • Abstract Number: 1094 • ACR Convergence 2020

    Long Term Open Label Extension of Study of Tofacitinib in Refractory Dermatomyositis

    Julie Paik1, Jemima Albayda1, Eleni Tiniakou1, Grazyna Purwin1, Andrew Koenig2 and Lisa Christopher-Stine1, 1Johns Hopkins University, Baltimore, MD, 2Pfizer Inc, New York City, NY

    Background/Purpose: Tofacitinib is a pan-JAK inhibitor that demonstrated safety and efficacy in a 12 week open label trial of 10 subjects with refractory dermatomyositis (NCT03002649).…
  • Abstract Number: 1089 • ACR Convergence 2020

    Intermuscular Adipose Tissue in Patients with Systemic Lupus Erythematosus

    Jorge Gamboa1, Daniel Carranza Leon1, Rachelle Crescenzi1, Adriana Marton2, Annette Oeser1, Cecilia Chung1, Jens Titze2, Michelle Ormseth1 and C. Michael Stein1, 1Vanderbilt University Medical Center, Nashville, TN, 2Duke NUS Medical School, Singapore, Singapore

    Background/Purpose: Patients with systemic lupus erythematosus (SLE) have reduced physical activity and frequently complain of fatigue. Exercise reduces fatigue in patients with SLE; however, the…
  • Abstract Number: 1102 • ACR Convergence 2020

    Neuropathic Pain in Inflammatory Hand Osteoarthritis(OA) Lowers Quality of Life and May Require Another Approach Than Anti-inflammatory Treatment

    Coen van der Meulen1, Lotte van de Stadt1, Féline Kroon2, Marion Kortekaas1, Annelies Boonen3, Stefan Böhringer4, Monique Reijnierse2, Frits Rosendaal2, Naghmeh Riyazi5, Mirian Starmans6, Franktien Turkstra7, Jende Van Zeben8, CF Allaart2 and Margreet Kloppenburg2, 1LUMC, Leiden, Netherlands, 2Leiden University Medical Center, Leiden, Netherlands, 3Maastricht University Medical Center, Maastricht, Netherlands, 4LUMC, Leiden, 5HAGA ziekenhuis, the hague, Netherlands, 6Zuyderland MC, Heerlen, Netherlands, 7Reade, Amsterdam, Netherlands, 8Franciscus Gasthuis & Vlietland, Rotterdam, Netherlands

    Background/Purpose: To investigate whether neuropathic pain is present in patients with inflammatory hand OA, to investigate characteristics of those patients and the impact of neuropathic…
  • Abstract Number: 1105 • ACR Convergence 2020

    RANK-L Activity: Understanding the Pathogenesis of Erosive Osteoarthritis

    Kalyna Jakibchuk1, Javier Rangel-Moreno1, Bethany Marston2, Jennifer Anolik1 and Allen Anandarajah1, 1University of Rochester Medical Center, Rochester, NY, 2University of Rochester Medical Center, Rochester

    Background/Purpose: Erosive osteoarthritis (EOA) is characterized by osteoarthritic findings with central erosions and collapse of the interphalangeal joint subchondral bone plate.  A number of studies…
  • Abstract Number: 1106 • ACR Convergence 2020

    MMP Mediated Type I Collagen Degradation Is Associated with Erosive Hand Osteoarthritis in a Hospital-based Observational Cohort – the NOR-HAND Study

    Christian Thudium1, Neha Sharma2, Marthe Gløersen3, Peder Frederiksen2, Anne C. Bay-Jensen1 and Ida Haugen3, 1Nordic Bioscience, Herlev, Denmark, 2Nordic Bioscience, Herlev, 3Diakonhjemmet Hospital, Oslo, Norway

    Background/Purpose: Hand osteoarthritis (OA) is a common degenerative joint disease affecting mainly the interphalangeal and first carpometacarpal joints. The disease manifests as inflammation and deterioration…
  • Abstract Number: 1101 • ACR Convergence 2020

    Effect of Transcutaneous Vagal Nerve Stimulation in Erosive Hand Osteoarthritis: Results from an Open-label Non-randomized Pilot Trial

    Alice Courties1, Camille Deprouw2, Emmanuel Maheu3, Eric Gibert4, Jacques-Eric Gottenberg5, Julien Champey6, Béatrice Banneville7, Camille Chesnel8, Gerard Amarenco8, Alexandra Rousseau9, Francis Berenbaum1 and Jeremie Sellam1, 1AP-HP, Hôpital Saint-Antoine, Service de Rhumatologie, Centre de Recherche Saint-Antoine, INSERM UMR_S 938,Sorbonne Université, Paris, 75012, France, Paris, France, 21. AP-HP, Hôpital Saint-Antoine, Service de Rhumatologie, Paris, 75012, France, Paris, France, 3AP-HP, Hôpital Saint-Antoine, Service de Rhumatologie, Paris, 75012, Paris, France, 4Cabinet de Rhumatologie, 94200 Ivry sur Seine, Paris, France, 5Service de Rhumatologie, Centre national de référence pour les maladies auto-immunes systémiques, Hôpital universitaire de Strasbourg, Université de Strasbourg, Strasbourg,, Strasbourg, France, 6AP-HP, Hôpital Saint-Antoine, Service de Rhumatologie, Paris, 75012,, paris, France, 7AP-HP, Hôpital Pitié-Salpêtrière, Service de Rhumatologie, Paris, 75013, Paris, France, 8Sorbonne Université, GRC 001, GREEN Groupe de Recherche Clinique en Neuro-Urologie, AP-HP, Hôpital Tenon, F-75020 Paris,, Paris, France, 9AP-HP, Hôpital Saint-Antoine, Unité de Recherche Clinique de l'Est Parisien (URC-Est), Paris, 75012,, Paris, France

    Background/Purpose: Beyond classical effect on vegetative functions, the activation of the vagus nerve inhibits inflammation and reduces the pain signal. Vagus nerve stimulation (VNS) can…
  • Abstract Number: 1112 • ACR Convergence 2020

    Relationship of Depth-Specific Subchondral Bone Mineral Density and Pain in Knee Osteoarthritis: The Multicenter Osteoarthritis Study

    Jean Liew1, JD Johnston2, Na Wang3, John Lynch4, Cora Lewis5, James Torner6 and Tuhina Neogi3, 1University of Washington, Seattle, WA, 2University of Saskatchewan, Saskatoon, SK, Canada, 3Boston University School of Medicine, Boston, MA, 4UCSF, San Francisco, CA, 5University of Alabama Birmingham, Birmingham, AL, 6University of Iowa, Iowa City, IA

    Background/Purpose: OA has traditionally been considered a disease of cartilage but early OA changes in subchondral bone may precede cartilage abnormalities. Altered subchondral bone mineral…
  • Abstract Number: 1109 • ACR Convergence 2020

    Pain in Women with Knee and/or Hip Osteoarthritis Is Related to Systemic Inflammation and to Adipose Tissue Dysfunction and Distribution: A Cross-sectional Metabolic Biomarkers Cohort Study

    Jeremie Sellam1, Anne-Christine Rat2, Soraya Fellahi3, Jean-Philippe Bastard4, Willy NGUEYON SIME5, Hang Korng EA6, Pascal Richette7, Jacqueline Capeau8, Francis Guillemin9 and Francis Berenbaum1, 1AP-HP, Hôpital Saint-Antoine, Service de Rhumatologie, Centre de Recherche Saint-Antoine, INSERM UMR_S 938,Sorbonne Université, Paris, 75012, France, Paris, France, 2Universite de Caen Normandie and Université de Lorraine, EA 4360, Caen, France, 3AP-HP INSERM, Paris, France, 4INSERM AP-HP UPEC, Paris, France, 5Universite de Lorraine, INSERM, CIC, Nancy, France, 6Universite de Paris, AP-HP, INSERM, paris, France, 7Department of Rheumatology, Lariboisière Hospital, Paris, France, 8INSERM Sorbonne Universite, Paris, France, 9Universite de Lorraine CIC INSERM, Nancy, France

    Background/Purpose: Beyond the link between metabolic diseases and osteoarthritis (OA) risk, some studies have suggested an association between metabolic syndrome or visceral obesity and OA-related…
  • Abstract Number: 1104 • ACR Convergence 2020

    The Disability Associated with Hand Osteoarthritis Is Substantial in a Cohort of Post-menopausal Women : The QUALYOR Study

    Maxime Auroux1, Blandine Merle2, Eric Lespessailles3 and Roland Chapurlat1, 1Hospices Civils de Lyon, Lyon Cedex 03, Rhone-Alpes, France, 2INSERM UMR 1033, Université de Lyon, Lyon Cedex 03, Rhone-Alpes, France, 3Regional Hospital and University of Orleans, Orléans, France

    Background/Purpose: Osteoarthritis (OA) is a highly prevalent disease, affecting more than 400 millions individuals around the world. Hand osteoarthritis (HOA) is the most frequent form…
  • Abstract Number: 0996 • ACR Convergence 2020

    Bacteria-Derived Indole Drives Autoimmune Arthritis by Altering B Cell Glycosylation of Autoantibodies

    Brandon Trent1, Meagan Chriswell2, Widian Jubair3 and Kristine Kuhn1, 1University of Colorado Anschutz Medical Campus, Aurora, CO, 2UC Denver SOM, Denver, CO, 3University of Colorado Denver, Denver, CO

    Background/Purpose: Background: Dysbiosis of gut bacterial communities in rheumatoid arthritis (RA) is a noted phenomenon in both murine models and human patients; however, the mechanisms…
  • « Previous Page
  • 1
  • …
  • 698
  • 699
  • 700
  • 701
  • 702
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology